Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02469701
Title BrUOG 317: Nivolumab and Ablation For Patients With Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors howard safran
Indications

lung non-small cell carcinoma

Therapies

Nivolumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Rhode Island Hospital Providence Rhode Island 02903 United States Details
The Miriam Hospital Providence Rhode Island 02906 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field